Isac Rodrigues Comia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Isac Rodrigues Comia has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Emilia Virginia Noormahomed
Department of Microbiology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique
3 shared publications - Irina Mendes Sousa
Mozambique Institute for Health Education and Research (MIHER), Maputo, Mozambique
3 shared publications - Regina Daniel Miambo
Mozambique Institute for Health Education and Research (MIHER), Maputo, Mozambique
3 shared publications Robert T Schooley
3 shared publications- Awa Abdul Carimo
Mozambique Institute for Health Education and Research (MIHER), Maputo, Mozambique
2 shared publications Constance Benson
Department of Medicine, Division of Infectious Diseases and Global Public Health, School of Medicine, University of California, San Diego, California, USA
2 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Research and Reports in Tropical Medicine
- Vol. ume 17, 1-11
Molecular Detection of Leptospira Species Among HIV-Infected Patients from Maputo Central Hospital, Mozambique: A Cross-Sectional Study
- 1 November 2026
- Published by Taylor & Francis in Research and Reports in Tropical Medicine
- Vol. ume 17, 1-11
Open AccessMolecular Detection of Leptospira Species Among HIV-Infected Patients from Maputo Central Hospital, Mozambique: A Cross-Sectional Study
- Open Access
- 1 June 2025
- Published by Taylor & Francis in Research and Reports in Tropical Medicine
- Vol. ume 16, 43-53
Seroprevalence and Risk Factors for Toxoplasma gondii Infection in People Living with HIV: A Cross-Sectional Study from Maputo Central Hospital, Mozambique
Background: This study aimed to determine the seroprevalence of toxoplasmosis in people living with HIV (PWH) in Maputo, Mozambique, exploring the interactions between HIV/acquired immunodeficiency syndrome (AIDS) and toxoplasmosis, including HIV-related factors such as the World Health Organization (WHO) HIV/AIDS clinical stage, degree of immunosuppression based on CD4+ T-cell count, and associated risk factors. Additionally, it aimed to assess the prevalence of neurological and psychiatric disorders (NPD) among study participants and its possible association with toxoplasmosis seropositivity. Methods: We conducted a descriptive, cross-sectional study of 200 patients aged > 18 years who were admitted to Maputo Central Hospital, Maputo, Mozambique, between March 2020 and October 2021. The participants were recruited by convenience, regardless of the reason for their admission. Sociodemographic and clinical data, such as age, sex, WHO HIV/AIDS stage, and CD4+ T-cell count, were collected. NPD disorders were assessed using the International Classification of Diseases criteria. Venous blood (5 mL) was obtained from each participant to determine anti-Toxoplasma gondii IgM and IgG antibodies using commercial enzyme-linked immunosorbent assay. Results: Participants were aged 18– 72 years, with the majority being female (64%) and unemployed (57%). Overall, 54.5% of patients tested positive for at least one anti-Toxoplasma gondii IgG (52%) or IgM (6.5%). Risk factors for Toxoplasma gondii infection (p < 0.05) were associated with age group 18– 28 years, being male and unemployed. Moreover, 68.5% of the participants had NPD and of those, 65.1% exhibited anti-Toxoplasma antibodies. We found a significant association between anxiety and IgM seropositivity for p = 0.016. Though three out of four participants with positive anti-Toxoplasma gondii IgG had mood disorders, no significant association was found between Toxoplasma gondii infection with mood disorders, nor with other NPD assessed (56% depression, 33% motor disorder, 25.5% psychosis, 17% cognitive impairment, 7.5% mental retardation). Conclusion: Toxoplasmosis may contribute to NPD in PWH patients. Further studies are recommended to better understand the complex interactions between Toxoplasma gondii, NPD disorders, and HIV. Plain Language Summary: Toxoplasmosis is a disease caused by the zoonotic and food-borne parasite, Toxoplasma gondii. It predominantly manifests in immunocompromised individuals, such as those living with human immunodeficiency virus (PWH), causing neurological and psychiatric impairments due to brain infections. The few existing studies in Mozambique on the burden of neurological and psychiatric disorders have not yet assessed the profile of neurological and psychiatric disorders in patients with HIV or the possible role that this parasite might play as a causative agent. The present study revealed that at least 54.5% of PWH were seropositive for Toxoplasma gondii antibodies and 68.5% had neurological and psychiatric disorders. Additionally, the majority (65.1%) of the patients with neurological and psychiatric disorders were seropositive for Toxoplasma gondii antibodies. Our findings highlight the need to screen for this parasite to clarify its role in the etiology of neurological and psychiatric disorders in both PWH and people without HIV for better healthcare delivery and management.
- 1 June 2025
- Published by Taylor & Francis in Research and Reports in Tropical Medicine
- Vol. ume 16, 43-53
Open AccessSeroprevalence and Risk Factors for Toxoplasma gondii Infection in People Living with HIV: A Cross-Sectional Study from Maputo Central Hospital, Mozambique
Background: This study aimed to determine the seroprevalence of toxoplasmosis in people living with HIV (PWH) in Maputo, Mozambique, exploring the interactions between HIV/acquired immunodeficiency syndrome (AIDS) and toxoplasmosis, including HIV-related factors such as the World Health Organization (WHO) HIV/AIDS clinical stage, degree of immunosuppression based on CD4+ T-cell count, and associated risk factors. Additionally, it aimed to assess the prevalence of neurological and psychiatric disorders (NPD) among study participants and its possible association with toxoplasmosis seropositivity. Methods: We conducted a descriptive, cross-sectional study of 200 patients aged > 18 years who were admitted to Maputo Central Hospital, Maputo, Mozambique, between March 2020 and October 2021. The participants were recruited by convenience, regardless of the reason for their admission. Sociodemographic and clinical data, such as age, sex, WHO HIV/AIDS stage, and CD4+ T-cell count, were collected. NPD disorders were assessed using the International Classification of Diseases criteria. Venous blood (5 mL) was obtained from each participant to determine anti-Toxoplasma gondii IgM and IgG antibodies using commercial enzyme-linked immunosorbent assay. Results: Participants were aged 18– 72 years, with the majority being female (64%) and unemployed (57%). Overall, 54.5% of patients tested positive for at least one anti-Toxoplasma gondii IgG (52%) or IgM (6.5%). Risk factors for Toxoplasma gondii infection (p < 0.05) were associated with age group 18– 28 years, being male and unemployed. Moreover, 68.5% of the participants had NPD and of those, 65.1% exhibited anti-Toxoplasma antibodies. We found a significant association between anxiety and IgM seropositivity for p = 0.016. Though three out of four participants with positive anti-Toxoplasma gondii IgG had mood disorders, no significant association was found between Toxoplasma gondii infection with mood disorders, nor with other NPD assessed (56% depression, 33% motor disorder, 25.5% psychosis, 17% cognitive impairment, 7.5% mental retardation). Conclusion: Toxoplasmosis may contribute to NPD in PWH patients. Further studies are recommended to better understand the complex interactions between Toxoplasma gondii, NPD disorders, and HIV. Plain Language Summary: Toxoplasmosis is a disease caused by the zoonotic and food-borne parasite, Toxoplasma gondii. It predominantly manifests in immunocompromised individuals, such as those living with human immunodeficiency virus (PWH), causing neurological and psychiatric impairments due to brain infections. The few existing studies in Mozambique on the burden of neurological and psychiatric disorders have not yet assessed the profile of neurological and psychiatric disorders in patients with HIV or the possible role that this parasite might play as a causative agent. The present study revealed that at least 54.5% of PWH were seropositive for Toxoplasma gondii antibodies and 68.5% had neurological and psychiatric disorders. Additionally, the majority (65.1%) of the patients with neurological and psychiatric disorders were seropositive for Toxoplasma gondii antibodies. Our findings highlight the need to screen for this parasite to clarify its role in the etiology of neurological and psychiatric disorders in both PWH and people without HIV for better healthcare delivery and management.
- Open Access
- 1 February 2024
- Published by Taylor & Francis in Research and Reports in Tropical Medicine
- Vol. ume 15, 1-11
A Cross Sectional Study on the Bidirectional Interactions Between Leptospirosis and HIV Infection Among Patients from Maputo Central Hospital, Mozambique
Introduction: This study aims to determine the baseline seroprevalence of leptospirosis, a zoonotic and neglected disease, in people living with HIV (PWH) in Maputo, Mozambique, and to evaluate the relationship between selected HIV-related factors that might influence risk of coinfection with leptospirosis, such as degree of immunosuppression, as assessed by CD4 cell count, World Health Organization (WHO) HIV/AIDS clinical stage and antiretroviral therapy (ART) intake. Methods: This was a descriptive cross-sectional analysis of 157 PWH, aged over 18 years old, admitted to the Maputo Central Hospital, in Maputo, Mozambique, between March 2020 and October 2021. The study participants were recruited as a convenience sample regardless of the reasons for their admission. We collected sociodemographic and clinical data, including ART and WHO HIV/AIDS clinical stage, and blood for CD4 cell count and detection of Leptospira IgG antibodies using a commercial Kit ab247199 Leptospira IgG ELISA (www.abcam.com/ab247199) with sensitivity and specificity of 100% and 97.3%, respectively. Laboratory testing was performed at the Faculty of Medicine, Eduardo Mondlane University and Laboratory of Clinical Analysis, in Maputo. Results: Participants were aged 18 to 72 years (median age 39 years; SD ± 10.5), the majority were female 100 (63.7%), from urban areas 138 (87.9%), with secondary-level education 80 (51%). The overall seroprevalence of Leptospira IgG antibodies was 40.1%. The median CD4 cell count was 385 cells/μl (02 to 2297; SD ± 378.47). Higher seroprevalence of Leptospira antibodies was found among participants with CD4 cell counts < 250 cells/μl (54.8%), WHO HIV/AIDS stage IV (70.2%) and those on ART (92%), though there were no statistically significant differences between groups with and without Leptospira antibodies. Conclusion: Our study confirmed that Leptospira antibodies are highly prevalent in PWH in Maputo; however, Leptospira infection was not associated with the degree of immunosuppression, WHO HIV/AIDS clinical stage, or the use of ART. Our data support the need for routine screening for leptospirosis in PWH in Mozambique. Future studies are warranted to characterize the incidence and outcomes of symptomatic leptospirosis in this patient population and to identify circulating serovars and species in the country and region, as well as the implicated reservoirs.
- 1 February 2024
- Published by Taylor & Francis in Research and Reports in Tropical Medicine
- Vol. ume 15, 1-11
Open AccessA Cross Sectional Study on the Bidirectional Interactions Between Leptospirosis and HIV Infection Among Patients from Maputo Central Hospital, Mozambique
Introduction: This study aims to determine the baseline seroprevalence of leptospirosis, a zoonotic and neglected disease, in people living with HIV (PWH) in Maputo, Mozambique, and to evaluate the relationship between selected HIV-related factors that might influence risk of coinfection with leptospirosis, such as degree of immunosuppression, as assessed by CD4 cell count, World Health Organization (WHO) HIV/AIDS clinical stage and antiretroviral therapy (ART) intake. Methods: This was a descriptive cross-sectional analysis of 157 PWH, aged over 18 years old, admitted to the Maputo Central Hospital, in Maputo, Mozambique, between March 2020 and October 2021. The study participants were recruited as a convenience sample regardless of the reasons for their admission. We collected sociodemographic and clinical data, including ART and WHO HIV/AIDS clinical stage, and blood for CD4 cell count and detection of Leptospira IgG antibodies using a commercial Kit ab247199 Leptospira IgG ELISA (www.abcam.com/ab247199) with sensitivity and specificity of 100% and 97.3%, respectively. Laboratory testing was performed at the Faculty of Medicine, Eduardo Mondlane University and Laboratory of Clinical Analysis, in Maputo. Results: Participants were aged 18 to 72 years (median age 39 years; SD ± 10.5), the majority were female 100 (63.7%), from urban areas 138 (87.9%), with secondary-level education 80 (51%). The overall seroprevalence of Leptospira IgG antibodies was 40.1%. The median CD4 cell count was 385 cells/μl (02 to 2297; SD ± 378.47). Higher seroprevalence of Leptospira antibodies was found among participants with CD4 cell counts < 250 cells/μl (54.8%), WHO HIV/AIDS stage IV (70.2%) and those on ART (92%), though there were no statistically significant differences between groups with and without Leptospira antibodies. Conclusion: Our study confirmed that Leptospira antibodies are highly prevalent in PWH in Maputo; however, Leptospira infection was not associated with the degree of immunosuppression, WHO HIV/AIDS clinical stage, or the use of ART. Our data support the need for routine screening for leptospirosis in PWH in Mozambique. Future studies are warranted to characterize the incidence and outcomes of symptomatic leptospirosis in this patient population and to identify circulating serovars and species in the country and region, as well as the implicated reservoirs.